Determining HIV incidence in populations: Moving in the right direction

Journal of Infectious Diseases

Volumn 207, Issue 2, 2013, Pages 204-206

  Mastro, Timothy D ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALGORITHM; ANTIBODY RESPONSE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MOLECULAR EPIDEMIOLOGY; NOTE; PANDEMIC; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; SEROLOGY; VIRUS STRAIN;

EID: 84871745210     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis661     Document Type: Note

References (27)

1. Mastro TD, Kim AA, Hallett T, et al. Estimating HIV incidence in populations using tests for recent infection: issues, challenges and the way forward. J HIV AIDS Surveill Epidemiol 2010; 2:1-14.
2. Busch MP, Pilcher CD, Mastro TD, et al. Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 2010; 24:2763-71.
3. Brookmeyer R. Measuring the HIV/AIDS epidemic: approaches and challenges. Epidemiol Rev. 2010; 32:26-37.
4. Hallett TB, Stover J, Mishra V, Ghys PD, Gregson S, Boerma T. Estimates of HIV incidence from household-based prevalence surveys. AIDS 2010; 24:147-52.
5. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280:42-8.
6. Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002; 18:295-307.
7. Le Vu S, Pillonel J, Semaille C, et al. Principles and uses of HIV incidence estimation from recent infection testing-a review. Euro Surveill 2008; Sept 4;13(36).
8. Murphy G, Parry JV. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 2008; 2008 Sept 4;13(36).
9. Family Health International, Bill and Melinda Gates Foundation. Assays to estimate HIV incidence and detect acute HIV infection: global landscape and market assessments. Research Triangle Park, NC: Family Health International, 2009.
10. Guy R, Gold J, Calleja JM, et al. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. Lancet Infect Dis 2009; 9:747-59.
11. Hargrove JW, Humphrey JH, Mutasa K, et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoas-say. AIDS 2008; 22:511-8.
12. Brookmeyer R. Should biomarker estimates of HIV incidence be adjusted? AIDS 2009; 23:485-91.
13. Brookmeyer R. On the statistical accuracy of biomarker assays for HIV incidence. J Acquir Immune Defic Syndr 2010; 54:406-14.
14. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008; 300:520-9.
15. Prejean J, Song R, Hernandez A, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS One 2011; 6:e17502.
16. Parekh BS, Hanson DL, Hargrove J, et al. Determination of mean recency period for estimation of HIV type 1 incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retrovi-ruses 2011; 27:265-73.
17. World Health Organization (WHO). When and how to use assays for recent infection to estimate HIV incidence at a population level. Geneva: WHO, 2011.
18. Incidence Assay Critical Path Working Group. More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Med 2011; 8: e1001045.
19. Laeyendecker O, Brookmeyer R, Cousins M, et al. HIV incidence determination in the United States: a multi-assay approach. J Infect Dis 2012. In press.
20. Eshleman SH, Hughes J, Laeyendecker O, et al. Comparison of three methods for assessing HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis 2012. In press.
21. Brookmeyer R, Quinn TC. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol 1995; 141:166-72.
22. Duong YT, Qiu M, De AK, et al. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One 2012; 7: e33328.
23. Parekh B, Duong YT, Mavenger Y, et al., editors. Performance of ne LAg-Avidity EIA to measure HIV-1 incidence in a cross-sectional population: Swaziland HIV Incidence Measurement Survey (SHIMS). Presented at: XIX International AIDS Conference, Washington, DC, 22-27 July 2012. Abstract no. LBPE27.
24. Reed JB, Justman J, Bicego G, et al. editors. Estimating national HIV incidence from directly observed seroconversions in the Swaziland HIV Incidence Measurement Survey (SHIMS) longitudinal cohort. Presented at: XIX International AIDS Conference, Washington, DC, 22-27 July 2012. Abstract no. FRLBX02.
25. Cousins MM, Laeyendecker O, Beauchamp G, et al. Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. PLoS One 2011; 6: e27211.
26. Cousins MM, Ou SS, Wawer MJ, et al. Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity. J Clin Microbiol 2012; 50:3054-9.
27. Ragonnet-Cronin M, Aris-Brosou S, Joanisse I, et al. Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED. J Infect Dis 2012; 206: 756-64.